- Home
- PBM vs ADXN Comparison
PBM vs ADXN Comparison
Compare PBM & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBM
- ADXN
- Stock Information
- Founded
- PBM 1994
- ADXN 2002
- Country
- PBM Canada
- ADXN Switzerland
- Employees
- PBM N/A
- ADXN N/A
- Industry
- PBM
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- PBM
- ADXN Health Care
- Exchange
- PBM NYSE
- ADXN Nasdaq
- Market Cap
- PBM 5.3M
- ADXN 8.0M
- IPO Year
- PBM N/A
- ADXN N/A
- Fundamental
- Price
- PBM $1.23
- ADXN $7.06
- Analyst Decision
- PBM
- ADXN Strong Buy
- Analyst Count
- PBM 0
- ADXN 1
- Target Price
- PBM N/A
- ADXN $30.00
- AVG Volume (30 Days)
- PBM 489.1K
- ADXN 21.3K
- Earning Date
- PBM 02-02-2025
- ADXN 03-24-2025
- Dividend Yield
- PBM N/A
- ADXN N/A
- EPS Growth
- PBM N/A
- ADXN N/A
- EPS
- PBM N/A
- ADXN 0.06
- Revenue
- PBM N/A
- ADXN $701,260.00
- Revenue This Year
- PBM N/A
- ADXN N/A
- Revenue Next Year
- PBM N/A
- ADXN N/A
- P/E Ratio
- PBM N/A
- ADXN $0.95
- Revenue Growth
- PBM N/A
- ADXN N/A
- 52 Week Low
- PBM $1.16
- ADXN $6.73
- 52 Week High
- PBM $323.25
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- PBM 34.72
- ADXN 42.98
- Support Level
- PBM $1.22
- ADXN $6.73
- Resistance Level
- PBM $1.59
- ADXN $7.90
- Average True Range (ATR)
- PBM 0.20
- ADXN 0.51
- MACD
- PBM 0.01
- ADXN -0.07
- Stochastic Oscillator
- PBM 7.95
- ADXN 16.34
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.